BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22236148)

  • 21. Evaluation of radiotherapy alone or in combination with doxorubicin chemotherapy for the treatment of cats with incompletely excised soft tissue sarcomas: 71 cases (1989-1999).
    Hahn KA; Endicott MM; King GK; Harris-King FD
    J Am Vet Med Assoc; 2007 Sep; 231(5):742-5. PubMed ID: 17764436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feline injection site-associated sarcoma: Is it a reason to critically evaluate our vaccination policies?
    Kirpensteijn J
    Vet Microbiol; 2006 Oct; 117(1):59-65. PubMed ID: 16769184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine-Associated Feline Sarcoma Task Force: a new model for problem solving in veterinary medicine.
    Starr RM
    J Am Vet Med Assoc; 1998 Nov; 213(10):1428-9. PubMed ID: 9828937
    [No Abstract]   [Full Text] [Related]  

  • 24. Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.
    Lawrence J; Saba C; Gogal R; Lamberth O; Vandenplas ML; Hurley DJ; Dubreuil P; Hermine O; Dobbin K; Turek M
    Vet Comp Oncol; 2012 Jun; 10(2):143-54. PubMed ID: 22236016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Musings on feline injection site sarcomas.
    Hendrick MJ
    Vet J; 2011 May; 188(2):130-1. PubMed ID: 20696602
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase I clinical trial of vinorelbine in tumor-bearing cats.
    Pierro JA; Mallett CL; Saba CF
    J Vet Intern Med; 2013; 27(4):943-8. PubMed ID: 23662626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
    Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
    J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).
    Rau SE; Burgess KE
    Vet Comp Oncol; 2017 Sep; 15(3):1019-1028. PubMed ID: 27277825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postvaccination sarcomas in cats.
    Thornburg LP
    J Am Vet Med Assoc; 1993 Jul; 203(2):193-6. PubMed ID: 8280243
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
    Cannon C; Borgatti A; Henson M; Husbands B
    J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA damage is a feature of feline injection-site sarcoma.
    Kang S; Southard T; Hume KR
    Vet Comp Oncol; 2017 Jun; 15(2):518-524. PubMed ID: 26781433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological and morphological analysis of feline injection site sarcomas.
    Kliczkowska K; Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
    Pol J Vet Sci; 2015; 18(2):313-22. PubMed ID: 26172181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postinflammatory sarcoma in cats.
    Jelínek F
    Exp Toxicol Pathol; 2003 Sep; 55(2-3):167-72. PubMed ID: 14620538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association between p53 SNP and FISS in a cat population from Germany.
    Mucha D; Laberke S; Meyer S; Hirschberger J
    Vet Comp Oncol; 2014 Jun; 12(2):130-7. PubMed ID: 22882519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Factors for Injection-Site Sarcomas in Cats.
    Harari J
    Compend Contin Educ Vet; 2008 Oct; 30(10):E7. PubMed ID: 23705145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential role of inflammation in the development of postvaccinal sarcomas in cats.
    Macy DW; Hendrick MJ
    Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):103-9. PubMed ID: 8825569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: a report on 69 cases.
    Martano M; Morello E; Ughetto M; Iussich S; Petterino C; Cascio P; Buracco P
    Vet J; 2005 Jul; 170(1):84-90. PubMed ID: 15993791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanocrystalline silver dressing and subatmospheric pressure therapy following neoadjuvant radiation therapy and surgical excision of a feline injection site sarcoma.
    Woods S; de Castro Marques AI; Renwick MG; Argyle SA; Yool DA
    J Feline Med Surg; 2012 Mar; 14(3):214-8. PubMed ID: 22370864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective analysis of radiation therapy for the treatment of feline vaccine-associated sarcoma.
    Eckstein C; Guscetti F; Roos M; Martín de las Mulas J; Kaser-Hotz B; Rohrer Bley C
    Vet Comp Oncol; 2009 Mar; 7(1):54-68. PubMed ID: 19222831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995-2000).
    Bregazzi VS; LaRue SM; McNiel E; Macy DW; Dernell WS; Powers BE; Withrow SJ
    J Am Vet Med Assoc; 2001 Feb; 218(4):547-50. PubMed ID: 11229507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.